Filing Details
- Accession Number:
- 0001127602-21-005677
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-16 11:58:32
- Reporting Period:
- 2021-02-11
- Accepted Time:
- 2021-02-16 11:58:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1141722 | C James Foster | 251 Ballardvale Street Wilmington MA 01887 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-11 | 2,128 | $281.32 | 255,041 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-11 | 3,766 | $282.39 | 251,275 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-11 | 727 | $282.96 | 250,548 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-11 | 4,038 | $284.21 | 246,510 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-11 | 9,643 | $285.15 | 236,867 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-11 | 2,490 | $286.48 | 234,377 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-11 | 4,775 | $287.18 | 229,602 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-11 | 2,402 | $287.99 | 227,200 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-11 | 31 | $289.16 | 227,169 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 19,013 | Indirect | 2019 GRAT |
| Common Stock | 20,000 | Indirect | 2020 GRAT |
| Common Stock | 340 | Indirect | By Trust |
| Common Stock | 750 | Indirect | By Trust |
| Common Stock | 2,250 | Indirect | By Trust |
| Common Stock | 10,000 | Indirect | Held By Spouse |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.
- This transaction was executed in multiple trades at prices ranging from $280.76 to $281.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $281.91 to $282.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $282.76 to $283.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $283.84 to $284.7075. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $284.80 to $285.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $285.765 to $286.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $286.76 to $287.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $287.76 to $288.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
